We are live on ! Find out more
INBS icon

Intelligent Bio Solutions

12 hedge funds and large institutions have $1.38M invested in Intelligent Bio Solutions in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

33% more funds holding

Funds holding: 912 (+3)

13% more capital invested

Capital invested by funds: $1.22M → $1.38M (+$163K)

0.47% more ownership

Funds ownership: 1.02%1.49% (+0.47%)

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

INBS Hedge Fund Activity: Q3 2025 in Review

12 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q3 2025, worth a combined $1.38M — up 13% from $1.22M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new INBS positions and 2 closed out — a net gain of 3 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $687K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $18.7K sold.

  • 12 institutional investors held Intelligent Bio Solutions (INBS) as of Q3 2025, up from 9 in Q2 2025.
  • Funds reported $1.38M of Intelligent Bio Solutions stock for Q3 2025, up 13% quarter-over-quarter.
  • 5 funds opened new Intelligent Bio Solutions positions in Q3 2025 and 2 closed out, a net change of +3 holders.
  • The largest Intelligent Bio Solutions buyer in Q3 2025 was ADAR1 Capital Management, an estimated $687K added.
  • The largest Intelligent Bio Solutions seller in Q3 2025 was Renaissance Technologies, an estimated $18.7K sold.

Based on aggregated 13F filings for Q3 2025.